ReNeuron Group (RENE) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Dec 2022 07:06 AM
RNS
Positive iPSC data presented at conference
02 Dec 2022 04:40 PM
RNS
Second Price Monitoring Extn
02 Dec 2022 04:35 PM
RNS
Price Monitoring Extension
02 Dec 2022 02:00 PM
RNS
Price Monitoring Extension
02 Dec 2022 07:00 AM
RNS
Interim Results
07 Oct 2022 07:00 AM
RNS
Positive Exosome data presented at US conference
22 Sep 2022 07:00 AM
RNS
ReNeuron to present new data at Exosome conference
14 Sep 2022 07:00 AM
RNS
Directorate and Executive Changes
09 Sep 2022 10:58 AM
RNS
Result of AGM
02 Sep 2022 11:01 AM
RNS
Director/PDMR Shareholding
01 Sep 2022 07:00 AM
RNS
Block Listing Review and Total Voting Rights
15 Aug 2022 03:25 PM
RNS
Posting of AR & Accounts & Notice of AGM
01 Aug 2022 07:00 AM
RNS
Directorate Change
15 Jul 2022 07:00 AM
RNS
Grant of Options
14 Jul 2022 07:00 AM
RNS
Share Purchase by a Director
13 Jul 2022 07:00 AM
RNS
Share Purchase by a Director
04 Jul 2022 07:00 AM
RNS
Preliminary Results
01 Jul 2022 07:00 AM
RNS
Fosun Tech Transfer and Supply Agreement update
20 Jun 2022 07:00 AM
RNS
Notice of Results
03 May 2022 07:00 AM
RNS
ReNeuron to present at ISCT 2022 in San Francisco
25 Apr 2022 07:00 AM
RNS
Director Declaration
23 Mar 2022 07:00 AM
RNS
Holding(s) in Company
22 Mar 2022 07:01 AM
RNS
Directorate Changes
22 Mar 2022 07:00 AM
RNS
Appointment of Nominated Adviser and Joint Broker
08 Mar 2022 07:00 AM
RNS
Block Listing Review and Total Voting Rights
07 Mar 2022 04:00 PM
RNS
Holding(s) in Company
02 Mar 2022 07:00 AM
RNS
Director exit arrangements
11 Feb 2022 04:41 PM
RNS
Second Price Monitoring Extn
11 Feb 2022 04:36 PM
RNS
Price Monitoring Extension
11 Feb 2022 02:38 PM
RNS
Holding(s) in Company
11 Feb 2022 07:00 AM
RNS
Director Change
10 Feb 2022 09:49 AM
RNS
Holding(s) in Company
09 Feb 2022 11:59 AM
RNS
Holding(s) in Company
04 Feb 2022 05:17 PM
RNS
Holding(s) in Company
28 Jan 2022 07:00 AM
RNS
Investor Presentation
26 Jan 2022 02:06 PM
RNS
Second Price Monitoring Extn
26 Jan 2022 02:01 PM
RNS
Price Monitoring Extension
18 Jan 2022 04:35 PM
RNS
Price Monitoring Extension
18 Jan 2022 02:06 PM
RNS
Second Price Monitoring Extn
18 Jan 2022 02:00 PM
RNS
Price Monitoring Extension
18 Jan 2022 11:05 AM
RNS
Second Price Monitoring Extn
18 Jan 2022 11:00 AM
RNS
Price Monitoring Extension
18 Jan 2022 09:05 AM
RNS
Second Price Monitoring Extn
18 Jan 2022 09:00 AM
RNS
Price Monitoring Extension
18 Jan 2022 07:00 AM
RNS
Strategic update
13 Jan 2022 07:00 AM
RNS
Additional agreement with Fosun Pharma for CTX
11 Jan 2022 07:00 AM
RNS
New Senior Appointment
17 Dec 2021 02:00 PM
RNS
Director Declaration
30 Nov 2021 07:00 AM
RNS
Interim Results
19 Nov 2021 07:00 AM
RNS
CTX-iPSC platform data shows commerical potential

ReNeuron Group plc is a United Kingdom-based clinical-stage stem cell company. The Company is engaged in the development of stem cell therapies targeting areas of unmet or poorly met medical need. It has developed a stem cell-derived, exosome-based, drug delivery platform with customizable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several exosome producer cell lines, its CustomEX platform can be optimized for specific tissue targets and payloads, leading to improvements in therapeutic outcome and a reduction in off-target effects. It offers a delivery mechanism for a variety of payloads such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. Through its conditionally immortalized induced pluripotent stem cell (iPSC) platform, it has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.

It listed on AIM in 2006 under the ticker RENE.

UK 100

Latest directors dealings